▲ BUY
5
/ 10
Conviction
$ Value
$102K
Shares
100,000
Price
$1
Filed
Aug 22
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Matheis Dennis
Title
—
CIK
0001817012
Roles
Director
Transaction Details
Transaction Date
2025-08-20
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
665,443
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.0085 to $1.0286. inclusive. The reporting person undertakes to provide to Lucid Diagnostics Inc., any security holder of Lucid Diagnostics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Filing Info
Matheis Dennis's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-20 | LUCD | A | $0 |
| 2025-09-11 | DRIO | A | $0 |
| 2025-08-20 | LUCD | ▲ | $102K |
| 2025-05-22 | LUCD | ▲ | $44K |
| 2025-05-21 | LUCD | ▲ | $172K |
| 2025-05-20 | LUCD | ▲ | $242K ★ |
Other Insiders at LUCD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PALUMBO JOHN R | — | — | 2026-02-20 |
|
MCGRATH DENNIS M
Chief Financial Officer
|
— | — | 2026-02-20 |
| SOKOLOV JACQUE J | — | — | 2026-02-20 |
|
Aklog Lishan
Chief Executive Officer
|
— | — | 2026-02-20 |
| Sparks Ronald M | — | — | 2026-02-20 |
| Cox James L | — | — | 2026-02-20 |
| Lapidus Stanley | — | — | 2026-02-20 |
| Matheis Dennis | — | — | 2026-02-20 |
| White Debra | — | — | 2026-02-20 |
|
O'Neil Shaun
President and COO
|
— | — | 2026-02-20 |
|
Gordon Michael Adam
General Counsel and Secretary
|
— | — | 2026-02-20 |